Bridge City Capital, LLC Amneal Pharmaceuticals, Inc. Transaction History

Bridge City Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 25, 2019	SELL	$6.44 - $14.29 $360,801 - $800,597	-56,025 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$11.87 - $14.84 $6,326 - $7,909	-533 Reduced 0.94%	56,025 $794,000
Q4 2018 Jan 30, 2019	BUY	$13.09 - $21.49 $80,163 - $131,604	6,124 Added 12.14%	56,558 $765,000
Q3 2018 Oct 25, 2018	SELL	$16.4 - $24.27 $34,964 - $51,743	-2,132 Reduced 4.06%	50,434 $1.12 Million
Q2 2018 Jul 23, 2018	BUY	$13.95 - $20.2 $733,295 - $1.06 Million	52,566 New	52,566 $863,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.26B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Bridge City Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridge City Capital, LLC with notifications on news.